111
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

, , , , , , , , & show all
Pages 5889-5900 | Published online: 27 Nov 2012

References

  • BanghamADStandishMMWatkinsJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol19651312382525859039
  • MaurerNFenskeDBCullisPRDevelopments in liposomal drug delivery systemsExpert Opin Biol Ther20011692394711728226
  • BoermanOCLavermanPOyenWJCorstensFHStormGRadiolabeled liposomes for scintigraphic imagingProg Lipid Res200039546147511082507
  • AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
  • DuncanRGasparRNanomedicine(s) under the microscopeMol Pharm2011862101214121974749
  • GabizonAAStealth liposomes and tumor targeting: one step further in the quest for the magic bulletClin Cancer Res20017222322511234871
  • LiSDHuangLStealth nanoparticles: high density but sheddable PEG is a key for tumor targetingJ Control Release2010145317818120338200
  • TiroshOBarenholzYKatzhendlerJPrievAHydration of polyethylene glycol-grafted liposomesBiophys J1998743137113799512033
  • ZhaoWZhuangSQiXRComparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesInt J Nanomedicine201163087309822163162
  • GrefRLuckMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
  • HerringsonTPAltinJGEffective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculatureInt J Pharm20114111–220621421443937
  • TorchilinVPTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
  • LattinJRBelnapDMPittWGFormation of eLiposomes as a drug delivery vehicleColloids Surf B Biointerfaces2012899310021962853
  • AshleyCECarnesECPhillipsGKThe targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersNat Mater201110538939721499315
  • LiZBChenKChenX(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin α(v)β(3) expressionEur J Nucl Med Mol Imaging20083561100110818204838
  • BarrettTBrechbielMBernardoMChoykePLMRI of tumor angiogenesisJ Magn Reson Imaging200726223524917623889
  • FerraraNKerbelRSAngiogenesis as a therapeutic targetNature2005438707096797416355214
  • WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis – correlation in invasive breast carcinomaN Engl J Med19913241181701519
  • GriffioenAWMolemaGAngiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammationPharmacol Rev200052223726810835101
  • HaubnerRWesterHJWeberWANoninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomographyCancer Res20016151781178511280722
  • DesgrosellierJSChereshDAIntegrins in cancer: biological implications and therapeutic opportunitiesNat Rev Cancer201010192220029421
  • HelbokADecristoforoCDobrozemskyGRadiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometalsJ Liposome Res201020321922719863193
  • MarikJTartisMSZhangHLong-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP)Nucl Med Biol200734216517117307124
  • TsaiCCChangCHChenLCBiodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis miceInt J Nanomedicine201162607261922114492
  • PetersenALBinderupTJolckRIPositron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse modelJ Control Release2012160225426322245688
  • JonasdottirTJFisherDRBorrebaekJBrulandOSLarsenRHFirst in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agentAnticancer Res2006264B2841284816886603
  • HenriksenGSchoultzBWMichaelsenTEBrulandOSLarsenRHSterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclidesNucl Med Biol200431444144915093814
  • BardDRKnightCGPage-ThomasDPEffect of the intra-articular injection of lutetium-177 in chelator liposomes on the progress of an experimental arthritis in rabbitsClin Exp Rheumatol1985332372424053442
  • McQuarrieSMercerJSymeASureshMMillerGPreliminary results of nanopharmaceuticals used in the radioimmunotherapy of ovarian cancerJ Pharm Pharm Sci200574293415850546
  • Mougin-DegraefMBourdeauCJestinEDoubly radiolabeled liposomes for pretargeted radioimmunotherapyInt J Pharm20073441–211011717592745
  • RojasSGispertJDMartinRBiodistribution of amino-functionalized diamond nanoparticles In vivo studies based on 18F radionuclide emissionACS Nano2011575552555921657210
  • NachmanRLLeungLLComplex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogenJ Clin Invest19826922632696460044
  • FrakerPJSpeckJCJrProtein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α,6α-diphenylglycolurilBiochem Biophys Res Commun1978804849857637870
  • HaubnerRWeberWABeerAJNoninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGDPLoS Med200523e7015783258
  • SuWWangHWangSPEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targetingInt J Pharm20124261–217018122266537
  • HoligPBachMVolkelTNovel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cellsProtein Eng Des Sel200417543344115235124
  • QinJChenDHuHQiaoMZhaoXChenBBody distribution of RGD-mediated liposome in brain-targeting drug deliveryYakugaku Zasshi200712791497150117827930
  • HelbokARanggerCVon GuggenbergETargeting properties of peptide-modified radiolabeled liposomal nanoparticlesNanomedicine20128111211821645641
  • FalcianiCAccardoABrunettiJTarget-selective drug delivery through liposomes labeled with oligobranched neurotensin peptidesChem Med Chem20116467868521370475
  • TorchilinVPKlibanovALHuangLO’DonnellSNossiffNDKhawBATargeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardiumFASEB J199269271627191612296
  • LiSGoinsBZhangLBaoANovel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imagingBioconjug Chem5222012 [Epub ahead of print.]
  • DuSLPanHLuWYWangJWuJWangJYCyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in ratsJ Pharmacol Exp Ther2007322256056817510318
  • ShokeenMPresslyEDHagoolyAEvaluation of multivalent, functional polymeric nanoparticles for imaging applicationsACS Nano20115273874721275414
  • JiangJYangSJWangJCSequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicinEur J Pharm Biopharm201076217017820600887
  • AccardoAMansiRMoriscoAPeptide modified nanocarriers for selective targeting of bombesin receptorsMol Biosyst20106587888720567774
  • MoriAKlibanovALTorchilinVPHuangLInfluence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Lett199128422632662060647
  • LehtinenJMagarkarAStepniewskiMAnalysis of cause of failure of new targeting peptide in PEGylated liposome: molecular modeling as rational design tool for nanomedicineEur J Pharm Sci201246312113022381076
  • MontetXFunovicsMMontet-AbouKWeisslederRJosephsonLMultivalent effects of RGD peptides obtained by nanoparticle displayJ Med Chem200649206087609317004722
  • LavermanPBrouwersAHDamsETPreclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid doseJ Pharmacol Exp Ther20002933996100110869403
  • MaheraniBArab-TehranyEKheirolomoomAReshetovVStebeMJLinderMOptimization and characterization of liposome formulation by mixture designAnalyst2012137377378622158519
  • BrinkhuisRPStojanovKLavermanPSize dependent biodistribution and SPECT imaging of (111)In-labeled polymersomesBioconjug Chem4122012 [Epub ahead of print.]
  • ZhaoHWangJCSunQSLuoCLZhangQRGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancerJ Drug Target2009171101819016068
  • LestiniBJSagnellaSMXuZSurface modification of liposomes for selective cell targeting in cardiovascular drug deliveryJ Control Release2002781–323524711772464
  • KnopKHoogenboomRFischerDSchubertUSPoly(ethylene glycol) in drug delivery: pros and cons as well as potential alternativesAngew Chem Int Ed Engl201049366288630820648499